955
Participants
Start Date
January 16, 2020
Primary Completion Date
November 30, 2027
Study Completion Date
December 31, 2028
Zanubrutinib
Participants will receive zanubrutinib at a dose of 160 mg twice daily (for a total daily dose of 320 mg), or the last dose level received in the BeiGene parent study.
Tislelizumab
Patients in Australia who participated in a parent study that involved combination therapy of zanubrutinib and tislelizumab will receive tislelizumab at a dose of 200mg every 3 weeks..
Auckland City Hospital, Auckland
Aotearoa Clinical Trials, Auckland
Royal North Shore Hospital, St Leonards
Concord Repatriation General Hospital, Concord
Westmead Hospital, Westmead
St George Hospital, Kogarah
Calvary Mater Newcastle, Waratah
Paratus Clinical Research Woden, Canberra
Border Medical Oncology, East Albury
Peter Maccallum Cancer Centre, Melbourne
The Alfred Hospital, Melbourne
St Vincents Hospital Melbourne, Fitzroy
Austin Health, Heidelberg
Tauranga Hospital, Tauranga
Box Hill Hospital, Box Hill
Cabrini Hospital Malvern, Malvern
Monash Health, Clayton
Peninsula Private Hospital, Frankston
Waikato Hospital, Hamilton Waikato
Barwon Health the Geelong Hospital, Geelong
Icon Cancer Centre Wesley, Auchenflower
Princess Alexandra Hospital, Brisbane
Brisbane Clinic For Lymphoma, Greenslopes
John Flynn Private Hospital, Tugun
Royal Adelaide Hospital, Adelaide
Icon Cancer Centre Kurralta Park, Kurralta Park
Flinders Medical Centre, Bedford PK
Royal Perth Hospital, Perth
Sir Charles Gairdner Hospital, Nedlands
Wellington Regional Hospital (Ccdhb), Wellington
Royal Hobart Hospital, Hobart
Christchurch Hospital, Christchurch
Hospital Clinic de Barcelona, Barcelona
Vseobecna Fakultni Nemocnice V Praze, Prague
University Hospital Vinohrady Hematology Department, Prague
Azienda Ospedaliera Citta Della Salute E Della Scienza Di Torino, Torino
National Cancer Center, Goyang-si
General Hospital of Athens Alexandra, Athens
Clinical Research Alliance, Inc, Westbury
Interhem Opieka Szpitalna, Bialystok
Ico Girona, Girona
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan
Oncology and Hematology Associates of Southwest Virginia, Inc, Roanoke
Irccs Policlinico San Matteo, Universita Degli Studi Di Pavi, Pavia
Duke University Hospital, Durham
Hospital Universitario Ramon Y Cajal, Madrid
Aou Maggiore Della Carita, Novara
Centre de Lutte Contre Le Cancer Institut Bergonie, Bordeaux
Aou Santa Maria Della Misericordia Di Udine, Udine
Scri Florida Cancer Specialists North, St. Petersburg
Florida Cancer Specialists Fort Myers, Fort Myers
Chu Tours Hopital Bretonneau, Tours
Hospital Universitario de Salamanca, Salamanca
Tennessee Oncology, Nashville
Scri Tennessee Oncology Chattanooga, Chattanooga
Forrest General Hospital Cancer Center, Hattiesburg
Policlinico Sorsola Malpighi, Aou Di Bologna, Bologna
Universita Degli Studi Di Modena Azienda Ospedaliere Policlinco, Modena
Hospital Universitario de Toledo, Toledo
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst, Meldola
Inje University Busan Paik Hospital, Busan
University of Michigan Health System, Ann Arbor
Unita Di Ematologia, Dipartimento Di Ematologia Ed Oncologia, Ravenna
Dong A University Hospital, Busan
Fakultni Nemocnice Hradec Kralove, Hradec Králové
Mayo Clinic Rochester, Rochester
Namik Kemal University, Tekirdağ
Fakultni Nemocnice Brno, Brno
University of Nebraska Medical Center, Omaha
Chu Hopital Lyon Sud, PierreBenite
Centre Hospitalier Le Mans, Le Mans
Carti Cancer Center, Little Rock
Srh Kliniken Landkreis Sigmaringen, Sigmaringen
Hopital Saint Louis, Paris
Fakultni Nemocnice Olomouc, Olomouc
Texas Oncology San Antonio Medical Center Usor, San Antonio
Rocky Mountain Cancer Centers Centennial, Centennial
Colorado Blood Cancer Institute, Denver
Banner Md Anderson Cancer Center, Gilbert
Centre Hospitalier Departemental de Vendee, La Roche-sur-Yon
Comprehensive Cancer Centers of Nevada, Las Vegas
Oregon Health and Science University, Portland
Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
University of Washington Seattle Cancer Alliance, Seattle
Medical Oncology Associates, Spokane
Peking University Third Hospital, Beijing
Peking University Peoples Hospital, Beijing
Beijing Cancer Hospital, Beijing
Peking Union Medical College Hospital, Beijing
Shengjing Hospital of China Medical University, Shenyang
The First Hospital of Jilin University, Changchun
Harbin Medical University Cancer Hospital, Harbin
Fudan University Shanghai Cancer Center, Shanghai
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
Jiangsu Province Hospital, Nanjing
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
Institute of Hematology and Hospital of Blood Disease, Tianjin
Tianjin Medical University Cancer Institute and Hospital, Tianjin
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Fujian Medical University Union Hospital, Fuzhou
Quanzhou First Affliated Hospital of Fujian Medical University, Quanzhou
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan
Henan Cancer Hospital, Zhengzhou
Guangdong Provincial Peoples Hospital, Guangzhou
Nanfang Hospital of Southern Medical University, Guangzhou
West China Hospital, Sichuan University, Chengdu
Dana Farber Cancer Institute, Boston
Summit Medical Group, Florham Park
Atlantic Health System, Morristown
Texas Oncology Fort Worth Cancer Center, Fort Worth
The University of Texas Md Anderson Cancer Center, Houston
Fakultni Nemocnice Ostrava, Ostrava
Fondazione Policlinico Universitario Agostino Gemelli, Roma
Azienda Ospedaliera S Maria Di Terni, Terni
Toyohashi Municipal Hospital, Toyohashi
Kurume University Hospital, Kurume
National Hospital Organization Hokkaido Cancer Center, Sapporo
Aiiku Hospital, Sapporo
Amsterdam Umc Amc, Amsterdam
Albert Schweitzer Ziekenhuis, Nijmegen
Universitair Medisch Centrum Utrecht, Utrecht
North Shore Hospital, Takapuna
Szpital Specjalist W Brzozowie,Podkarpacki Osrodek Onkologiczny, Brzozów
Szpital Uniwersytecki Nr Im Dr Jana Biziela, Bydgoszcz
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich, Chorzów
Uniwersyteckie Centrum Kliniczne, Gdansk
Copernicus Podmiot Leczniczy Sp Z Oo Wojewodzkie Centrum Onkologii, Gdask
Malopolskie Centrum Medyczne Sc, Krakow
Wielospecjalistyczne Centrum Onkologii I Traumatologii Im M Kopernika W Lodzi, Lodz
Centrum Medyczne Pratia Poznan, Skorzewo Poznan
Severance Hospital Yonsei University Health System, Seoul
Samsung Medical Center Hematology Oncology, Seoul
Hospital de La Santa Creu I Sant Pau, Barcelona
Hospital Universitario Vall Dhebron, Barcelona
Ico Hug Trias I Pujol, Barcelona
Skanes Universitetssjukhus I Lund, Lund
Karolinska Universitetssjukhuset Solna, Stockholm
Nhs Grampian Ppds, Aberdeen
Birmingham Heartlands Hospital, Birmingham
The Royal Bournemouth and Christchurch Hospitals Nhs Foundation, Bournemouth
Kent and Canterbury Hospital, Canterbury
Beatson West of Scotland Cancer Centre, Glasgow
The Christie Hospital, Greater Manchester
Churchill Hospital Oxford University Hospital Nhs Trust, Headington
St Jamess Institute of Oncology, Leeds
Barts Health Nhs Trust, London
University College Hospital, London
Nottingham University Hospitals Nhs Trust, Nottingham
Plymouth Hospitals Nhs Trust, Plymouth
Southampton General Hospital, Southampton
Lead Sponsor
BeiGene
INDUSTRY